| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ocugen, Inc. | Chief Scientific Officer, Head of Research, Development and Medical | Common Stock | 349K | $495K | $1.42 | Jun 17, 2024 | Direct |
| Ocugen, Inc. | Chief Scientific Officer, Head of Research, Development and Medical | Option (Right to Buy) | 138K | Jan 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OCGN | Ocugen, Inc. | Jun 17, 2024 | 1 | -$1.3K | 4 | Jul 2, 2024 | Chief Scientific Officer, Head of Research, Development and Medical |
| OCGN | Ocugen, Inc. | Jan 3, 2024 | 1 | -$27.2K | 4 | Jan 5, 2024 | Chief Scientific Officer, Head of Research, Development and Medical |
| OCGN | Ocugen, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Scientific Officer, Head of Research, Development and Medical |
| OCGN | Ocugen, Inc. | Sep 16, 2023 | 1 | -$345 | 4 | Sep 19, 2023 | Chief Scientific Officer, Head of Research, Development and Medical |
| OCGN | Ocugen, Inc. | Jun 16, 2023 | 1 | -$468 | 4 | Jun 20, 2023 | Chief Scientific Officer |
| OCGN | Ocugen, Inc. | Jan 3, 2023 | 1 | -$8.88K | 4 | Feb 17, 2023 | Chief Scientific Officer |
| OCGN | Ocugen, Inc. | Jan 3, 2023 | 2 | $0 | 4 | Jan 5, 2023 | Chief Scientific Officer |
| OCGN | Ocugen, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 5, 2023 | Chief Scientific Officer |